Moleculin Biotech
MBRX
MBRX
24 hedge funds and large institutions have $5.31M invested in Moleculin Biotech in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.02% more ownership
Funds ownership: 0.08% → 0.1% (+0.02%)
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.35M | |
| 2 | +$846K | |
| 3 | +$80.9K | |
| 4 |
Morgan Stanley
New York
|
+$23.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$20K |
Top Sellers
| 1 | -$294K | |
| 2 | -$179K | |
| 3 | -$20K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$12K |
| 5 |
IWP
Icon Wealth Partners
Houston,
Texas
|
-$1K |